A recent study highlights a key discovery that challenges previous assumptions about the role of an important immune protein, tumor necrosis factor (TNF), in infectious disease (Figure 1). This insight was made possible using a human cell culture model that mimics the lung’s essential immune cells, alveolar macrophages. The model is transforming the way scientists study immune responses in the lungs.
Alveolar macrophages reside deep within the lungs, where they play a critical role in clearing pathogens like bacteria and viruses. However, obtaining these specialized cells for research traditionally requires invasive, time-consuming, and costly procedures. The researchers devised an innovative method to generate “alveolar macrophage-like” (AML) cells in the laboratory. These cells closely resemble the native alveolar macrophages, offering an easier, non-invasive alternative for research.
This model has already made significant contributions to global biomedical research. In the recent studies, AML cells were used alongside other cell-based models and extensive human genetic studies to investigate TNF’s function in tuberculosis (TB). The research offers a new perspective on TNF’s role in the immune system.
Traditionally, TNF has been considered essential for protecting against a broad range of infections. However, this study shows that while TNF is critical in defending against TB, it does not play the same role in other infectious diseases.
The AML model, combined with other experimental approaches, helped researchers uncover why TNF is so crucial in TB. TNF triggers the release of reactive oxygen species (ROS) within alveolar macrophages, which are key molecules that help eliminate Mycobacterium tuberculosis, the bacteria responsible for TB. In the absence of TNF, ROS production is impaired, allowing the bacteria to spread within the lungs.
The AML model offers significant advantages over previous methods, which required invasive lung washes to collect alveolar macrophages. Other macrophage models exist, but they often lack the unique features of alveolar macrophages. The AML model, derived from a simple blood draw, transforms blood monocytes into cells that closely mimic alveolar macrophages within a week. These cells are now being tested in more complex lung-on-chip models and with stem cells to generate even larger quantities for future studies.
Journal article: Arias, A.A., et al., 2024. Tuberculosis in otherwise healthy adults with inherited TNF deficiency. Nature.
Summary by Stefan Botha